Theodosios D Filippatos Selected Research

Hypertension (High Blood Pressure)

1/2018	Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions.
1/2018	Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodosios D Filippatos Research Topics

Disease

17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 06/2006
8	Dyslipidemias (Dyslipidemia) 09/2017 - 07/2007
7	Hyponatremia 07/2021 - 09/2013
7	Type 2 Diabetes Mellitus (MODY) 01/2019 - 03/2010
6	Hyperlipidemias (Hyperlipidemia) 01/2024 - 09/2005
6	Atherosclerosis 12/2023 - 01/2008
6	Body Weight (Weight, Body) 01/2023 - 02/2015
5	Heart Failure 03/2019 - 04/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012 - 04/2006
4	Obesity 01/2023 - 01/2010
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2008
4	Hypercholesterolemia 01/2019 - 03/2010
4	Hypertriglyceridemia 01/2019 - 07/2006
4	Diabetes Mellitus 01/2018 - 03/2008
4	Neoplasms (Cancer) 01/2018 - 01/2008
4	Weight Loss (Weight Reduction) 01/2017 - 01/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 10/2013
3	Albuminuria 01/2019 - 01/2015
3	Infections 01/2019 - 10/2011
3	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 10/2013
3	Insulin Resistance 01/2017 - 09/2005
3	Pancreatitis 11/2014 - 01/2014
3	Non-alcoholic Fatty Liver Disease 10/2011 - 01/2008
2	Inflammation (Inflammations) 12/2023 - 12/2011
2	COVID-19 11/2023 - 01/2023
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 02/2015
2	Hypertension (High Blood Pressure) 01/2018 - 01/2018
2	Vascular Diseases (Vascular Disease) 09/2017 - 03/2008
2	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 06/2016
2	Stroke (Strokes) 01/2017 - 07/2006
2	Inappropriate ADH Syndrome (SIADH) 04/2016 - 02/2016
2	Neurologic Manifestations (Neurological Manifestations) 02/2016 - 09/2013
2	Prediabetic State (Prediabetes) 01/2016 - 06/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 06/2014
2	Abdominal Pain (Pain, Abdominal) 01/2014 - 01/2008
2	Overweight 10/2011 - 08/2008
2	Rheumatoid Arthritis 10/2009 - 05/2006
1	Multiple Myeloma 12/2023

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2018 - 09/2005
9	ElectrolytesIBA 07/2021 - 12/2005
8	Triglycerides (Triacylglycerol)IBA 01/2024 - 07/2007
8	Rosuvastatin Calcium (Crestor)FDA Link 01/2024 - 09/2005
8	SodiumIBA 07/2021 - 12/2005
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 04/2008
7	oxidized low density lipoproteinIBA 01/2024 - 04/2006
7	LDL CholesterolIBA 09/2017 - 04/2006
7	Lipoproteins (Lipoprotein)IBA 08/2013 - 05/2006
6	HDL CholesterolIBA 12/2023 - 07/2006
5	Fenofibrate (CiL)FDA LinkGeneric 01/2024 - 08/2008
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2013
5	Orlistat (Xenical)FDA Link 10/2011 - 01/2008
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2024 - 10/2011
4	Lipoprotein(a)IBA 01/2024 - 07/2006
4	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2019 - 04/2017
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 10/2009
4	Fibric Acids (Fibrates)IBA 01/2019 - 08/2013
4	HDL LipoproteinsIBA 01/2019 - 10/2011
4	Drug CombinationsIBA 01/2019 - 03/2010
4	Ezetimibe (Zetia)FDA Link 01/2019 - 03/2011
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2024 - 12/2011
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 10/2013
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 10/2013
3	CalciumIBA 03/2019 - 12/2005
3	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019 - 01/2014
3	Uric Acid (Urate)IBA 01/2019 - 09/2005
3	Insulin (Novolin)FDA Link 01/2018 - 01/2014
3	ApolipoproteinsIBA 01/2017 - 07/2006
3	CholesterolIBA 01/2017 - 10/2011
3	Vasopressins (Vasopressin)IBA 01/2017 - 02/2016
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2011
2	Apoprotein(a) (Apolipoprotein (a))IBA 12/2023 - 07/2006
2	Oxygen (Dioxygen)IBA 11/2023 - 09/2022
2	Monoclonal AntibodiesIBA 01/2023 - 04/2016
2	DiureticsIBA 03/2019 - 02/2016
2	dapagliflozinIBA 01/2019 - 02/2015
2	ThiazidesIBA 01/2017 - 02/2016
2	Simvastatin (Zocor)FDA LinkGeneric 01/2016 - 01/2015
2	AcidsIBA 05/2015 - 12/2005
2	Metformin (Glucophage)FDA LinkGeneric 02/2015 - 11/2014
2	HomocysteineIBA 01/2015 - 09/2005
2	CreatinineIBA 01/2015 - 09/2005
2	Exenatide (Byetta)FDA Link 11/2014 - 10/2013
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2014 - 09/2013
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2014 - 03/2011
2	EnzymesIBA 06/2013 - 10/2011
2	Apolipoproteins AIBA 10/2011 - 07/2006
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 04/2010 - 03/2010
2	sibutramine (Meridia)FDA Link 04/2010 - 03/2010
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2010 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 05/2006
2	AdipokinesIBA 10/2009 - 01/2008
2	Infliximab (Remicade)FDA Link 10/2009 - 05/2006
2	Dihydrotachysterol (AT 10)IBA 03/2009 - 09/2005
1	N 30IBA 01/2024
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2023
1	InterleukinsIBA 12/2023
1	Interleukin-6 InhibitorsIBA 12/2023

Therapy/Procedure

9	Therapeutics 01/2024 - 05/2006
2	Glycemic Control 11/2014 - 10/2013